Crescent Capital BDC, Inc. (CCAP) Tops Q4 EPS by 5c

Crescent Capital BDC, Inc. (NASDAQ: CCAP) reported Q4 EPS of $0.49, $0.05 better than the analyst estimate of $0.44.

For earnings history and earnings-related data on Crescent Capital BDC, Inc. (CCAP) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c